Top Markets
Coin of the day
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation

InVivo Therapeutics Holdings Corporation

NVIV
Rangering i aksjer #39771
InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm,... InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold. This device is engineered to be implanted directly at the site of injury within the spinal cord, aiming to treat acute SCI. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.
Aksjekurs
$0.26
Sist synkronisert: 2024-03-11
Markedsverdi
$356.29K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel InVivo Therapeutics Holdings Corporation (NVIV)

Kategori

EPS for InVivo Therapeutics Holdings Corporation (NVIV)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til InVivo Therapeutics Holdings Corporation er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for InVivo Therapeutics Holdings Corporation fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter